AAN: Obstructive Sleep Apnea Linked to Increased Incidence of Parkinson Disease
By Elana Gotkine HealthDay Reporter
TUESDAY, March 4, 2025 -- Obstructive sleep apnea (OSA) is associated with an increased risk for Parkinson disease (PD), according to a study scheduled for presentation at the annual meeting of the American Academy of Neurology, to be held from April 5 to 9 in San Diego.
Isabella Montano, from the Veterans Affairs (VA) Portland Health Care System in Oregon, and colleagues assessed the risk for PD in patients with OSA and examined the impact of early versus late continuous positive airway pressure (CPAP) treatment using data from the VA Corporate Data Warehouse spanning 20+ years and more than 20 million veterans.
Overall, 1,552,505 OSA-positive and 9,759,246 OSA-negative veterans were identified. The researchers found that OSA-positive was associated with a significantly increased risk for PD after inverted probability treatment weighting analysis, balancing birthyear/age, sex, smoking status, race, ethnicity, pseudo-randomization by covariates, and adjustment for competing risk for death, with 1.8 extra PD cases per 1,000 people at five years after onset of OSA. The incidence of PD was similar for the late use of CPAP (more than two years since OSA diagnosis) versus no use of CPAP. In contrast, a significantly lower incidence of PD was seen with early use of CPAP (within two years of diagnosis), with a reduction of 2.3 cases of PD five years after OSA onset.
"While our study found an increased risk of Parkinson's disease, the good news is people can do something about it, by using CPAP as soon as they are diagnosed with the sleep disorder," coauthor Gregory D. Scott, M.D., Ph.D., also from the VA Portland Health Care System, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea
MONDAY, June 9, 2025 -- Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with...
Autism Spectrum Disorder Linked to Increased Risk for Parkinson Disease
TUESDAY, June 3, 2025 -- Autism spectrum disorder (ASD) is associated with an increased risk for Parkinson disease (PD), according to a study published online May 27 in JAMA...
Wearable Sensor Can Monitor Sleep Apnea Treatment Response
MONDAY, May 19, 2025 -- A wearable pulse oximeter and connected software platform (Apnimed) shows promise for monitoring obstructive sleep apnea (OSA) and other sleep-related...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.